HomePCSA • NASDAQ
Processa Pharmaceuticals Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.85M | 1.33% |
Net income | -2.83M | -3.96% |
Net profit margin | — | — |
Earnings per share | -0.30 | 72.97% |
EBITDA | -2.85M | -1.33% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.90M | -67.52% |
Total assets | 4.81M | -51.64% |
Total liabilities | 1.28M | 20.88% |
Total equity | 3.53M | — |
Shares outstanding | 11.88M | — |
Price to book | 0.37 | — |
Return on assets | -177.08% | — |
Return on capital | -266.28% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.83M | -3.96% |
Cash from operations | -2.73M | -33.24% |
Cash from investing | — | — |
Cash from financing | 4.44M | -29.18% |
Net change in cash | 1.71M | -59.52% |
Free cash flow | -2.18M | -72.26% |
Previous close
$0.25
Day range
$0.23 - $0.24
Year range
$0.15 - $3.10
Market cap
2.82M USD
Avg Volume
3.44M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2011
Headquarters
Website
Employees
10
